🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Veradermics, Incorporated

MANE Healthcare
$111.23 $-0.08 (-0.07%)
Market Cap: $4.65 B
Gurus Holding
3
Popularity Rank
#3109
% of Shares Held
5.82%
Net Activity (Q2 2026)
+$91.32 M

Guru Ownership Trend

Guru Analysis for Veradermics, Incorporated (MANE)

Veradermics, Incorporated (MANE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $270.66 M.

Top institutional holders include Andreas Halvorsen and Lee Ainslie.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $91.32 M net inflow during the quarter.

Recent activity highlights Lee Ainslie who opened a new position. Conversely, Andreas Halvorsen reduced exposure by 7.6%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$107.18 M
Total Buy Value
New Buys 2
Additions 0
-$15.87 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Veradermics, Incorporated (MANE)

Major holders include Andreas Halvorsen ($191.97 M), Lee Ainslie ($97.12 M), Renaissance Technologies (RenTech) ($10.06 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.43 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $91.32 M, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited MANE. The total reported sell value was $15.87 M.

Yes, 2 managers opened new positions in MANE, and 0 increased their existing holdings. The total reported buy value was $107.18 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.55% Reduce -7.6% 1,561,494 $191.97 M Q2 2026
0.86% New Buy 789,980 $97.12 M Q2 2026
0.01% New Buy 81,852 $10.06 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form